Docetaxel and cisplatin in patients with advanced gastric cancer: results of Japanese phase I/II study

被引：1
|
作者：
Soh Saitoh
Yuh Sakata
机构：
[1] Aomori Prefectural Central Hospital,
[2] Misawa Municipal Hospital,undefined
来源：
Gastric Cancer | 2002年 / 5卷 / Suppl 1期
关键词：
Docetaxel; Cisplatin; Gastric cancer;
D O I：
10.1007/s10120-002-0209-0
中图分类号：
学科分类号：
摘要：
Two phase II monotherapy studies of docetaxel in patients with advanced gastric cancer were performed in Japan. In group A, docetaxel showed an overall response rate of 23.7% (14/59) in 59 patients, and the adverse reactions were tolerable. In group B, this agent showed the same response rate, of 23.7% (14/59) and the same adverse reaction profile.
引用
收藏
页码：23 / 26
页数：3
相关论文
共 50 条
  • [1] Docetaxel and cisplatin in patients with advanced or recurrent gastric cancer: A multicenter phase I/II study
    Mitachi Y.
    Sakata Y.
    Ohtsu A.
    Hyodo I.
    Katsu K.
    Sairenji M.
    Saitoh S.
    Suwa T.
    Sato T.
    Miyata Y.
    Gastric Cancer, 2002, 5 (3) : 160 - 167
  • [2] Phase II trial of weekly docetaxel/fluorouracil/cisplatin in patients with advanced gastric cancer: Preliminary results
    Evangelista, W.
    Racca, P.
    Fanchini, L.
    Ritorto, G.
    Ciorba, A.
    Facilissimo, I
    Napoletano, R.
    Fusco, V
    Alabiso, O.
    ANNALS OF ONCOLOGY, 2008, 19 : 48 - 48
  • [3] Phase I Study of Docetaxel, Cisplatin and S-1 in Patients with Advanced Gastric Cancer
    Hironaka, Shuichi
    Yamazaki, Kentaro
    Taku, Keisei
    Yokota, Tomoya
    Shitara, Kohei
    Kojima, Takashi
    Ueda, Shinya
    Machida, Nozomu
    Muro, Kei
    Boku, Narikazu
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2010, 40 (11) : 1014 - 1020
  • [4] Phase II study of docetaxel combined with cisplatin in advanced gastric cancer.
    Park, YS
    Park, KW
    Lee, J
    Kang, JH
    Kim, HY
    Park, JO
    Lee, SH
    Kang, WK
    Park, K
    Lee, SI
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 327S - 327S
  • [5] Phase I/II study of docetaxel and S-I in patients with advanced gastric cancer
    Yamaguchi, K.
    Shimamura, T.
    Hyodo, I.
    Koizumi, W.
    Doi, T.
    Narahara, H.
    Komatsu, Y.
    Kato, T.
    Saitoh, S.
    Akiya, T.
    Munakata, M.
    Miyata, Y.
    Maeda, Y.
    Takiuchi, H.
    Nakano, S.
    Esaki, T.
    Kinjo, F.
    Sakata, Y.
    BRITISH JOURNAL OF CANCER, 2006, 94 (12) : 1803 - 1808
  • [6] Phase II study of docetaxel, cisplatin, and irinotecan in advanced esophageal and gastric cancer.
    Enzinger, PC
    Clark, J
    Ryan, D
    Meyerhardt, J
    Kulke, M
    Fidias, P
    Earle, C
    Vincitore, M
    Michelini, A
    Fuchs, C
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 323S - 323S
  • [7] A Multicentre phase II study of docetaxel plus cisplatin for the treatment of advanced gastric cancer
    Fahlke, J.
    Ridwelski, K.
    Schmidt, C.
    Hribaschek, K.
    Stuebs, P.
    Kettner, E.
    Quietzsch, D.
    Assmann, M.
    Deist, T.
    Keilholz, U.
    Lippert, H.
    CHEMOTHERAPY, 2007, 53 (06) : 454 - 460
  • [8] Phase I/II study of docetaxel and S-1 in patients with advanced gastric cancer
    K Yamaguchi
    T Shimamura
    I Hyodo
    W Koizumi
    T Doi
    H Narahara
    Y Komatsu
    T Kato
    S Saitoh
    T Akiya
    M Munakata
    Y Miyata
    Y Maeda
    H Takiuchi
    S Nakano
    T Esaki
    F Kinjo
    Y Sakata
    British Journal of Cancer, 2006, 94 : 1803 - 1808
  • [9] A phase I/II trial of docetaxel and oxaliplatin in patients with advanced gastric cancer
    Kim, Kyoung Ha
    Park, Young Suk
    Chang, Myung Hee
    Kim, Hyo Song
    Jun, Hyun Jung
    Uhm, Jieun
    Yi, Seong Yoon
    Lim, Do Hyoung
    Ji, Sang Hoon
    Park, Min Jae
    Lee, Jeeyun
    Park, Se Hoon
    Park, Joon Oh
    Lim, Ho Yeong
    Kang, Won Ki
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2009, 64 (02) : 347 - 353
  • [10] A phase I/II trial of docetaxel and oxaliplatin in patients with advanced gastric cancer
    Kyoung Ha Kim
    Young Suk Park
    Myung Hee Chang
    Hyo Song Kim
    Hyun Jung Jun
    Jieun Uhm
    Seong Yoon Yi
    Do Hyoung Lim
    Sang Hoon Ji
    Min Jae Park
    Jeeyun Lee
    Se Hoon Park
    Joon Oh Park
    Ho Yeong Lim
    Won Ki Kang
    Cancer Chemotherapy and Pharmacology, 2009, 64 : 347 - 353
12345